SkinMedica Buys Facial Hair Treatment Vaniqa From Women First HealthCare
This article was originally published in The Pink Sheet Daily
The $36.6 mil. deal represents the second time Vaniqa is changing hands in as many years. SkinMedica will re-launch the product with a focus on dermatologist detailing.
You may also be interested in...
Women First Healthcare is looking for a buyer to avoid filing for Chapter 11 bankruptcy
Senior VP-Global Clinical & Pharmaceutical Development Elliott Sigal is acting president of Bristol-Myers Squibb’s research institute following the death of James Palmer.
The four-pronged plan will address “bio-burden,” manufacturing techniques, quality systems and execution, CEO Pien says. Chiron has met twice with U.K. authorities and hopes to realize similar progress with FDA soon.